These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9160072)

  • 41. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of focal dystonia with botulinum toxin].
    Nagamine T; Kaji R; Hamano T; Kimura J
    Rinsho Shinkeigaku; 1991 Jan; 31(1):32-7. PubMed ID: 2044303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of treatment with botulinum toxin on neurogenic blepharospasm.
    Elston JS; Russell RW
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1857-9. PubMed ID: 3924284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
    Racette BA; McGee-Minnich L; Perlmutter JS
    Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A preliminary report of the use of botulinum toxin type A in infants with clubfoot: four case studies.
    Delgado MR; Wilson H; Johnston C; Richards S; Karol L
    J Pediatr Orthop; 2000; 20(4):533-8. PubMed ID: 10912614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
    Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
    Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meige's syndrome and hemichorea associated with hyperthyroidism.
    Miao J; Liu R; Li J; Du Y; Zhang W; Li Z
    J Neurol Sci; 2010 Jan; 288(1-2):175-7. PubMed ID: 19883923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Posterior laryngeal stenosis in patient with Meige's Syndrome].
    Pino Rivero V; Marcos García M; Trinidad Ruíz G; Pardo Romero G; González Palomino A; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(4):349-54. PubMed ID: 15382486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
    Guntinas-Lichius O
    Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
    [No Abstract]   [Full Text] [Related]  

  • 57. [Botulinum toxin treatment of patients with oromandibular dystonia].
    Erdal J; Werdelin LM; Prytz S; Fuglsang-Frederiksen A; Møller E
    Ugeskr Laeger; 2000 Nov; 162(48):6567-71. PubMed ID: 11187229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.